<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03854058</url>
  </required_header>
  <id_info>
    <org_study_id>WI_18-340</org_study_id>
    <nct_id>NCT03854058</nct_id>
  </id_info>
  <brief_title>Respiratory Muscle Strength in Patients With Obesity Hypoventilation Syndrome (OHS) or With a Precursor of the Disease</brief_title>
  <official_title>Multimodal Measurement of Respiratory Muscle Strength by Using Volitional and Non-volitional Tests in Patients With Obesity Hypoventilation Syndrome (OHS), Obesity-associated Hypoventilation and OHS-Risk-Patients to Evaluate Pathophysiological Determinants and Predictors for the Presence of a Sleep-related Hypoventilation Requiring Treatment in Obese Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wissenschaftliches Institut Bethanien e.V</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wissenschaftliches Institut Bethanien e.V</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using an extensive set of both volitional and non-volitional tests of respiratory muscle
      function and strength it is the aim of this study to

        -  identify potential determinants for the development of obesity hypoventilation

        -  to identify predictors for the presence of a sleep-related hypoventilation requiring
           treatment in obese patients
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2019</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Carbon dioxide rebreathing test</measure>
    <time_frame>1 day</time_frame>
    <description>minute volumen (L/min)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>transdiaphragmatic pressure (non-volitional)</measure>
    <time_frame>1 day</time_frame>
    <description>difference between intraesophageal and intragastral pressure after posterior magnetic stimulation of the phrenic nerves</description>
  </primary_outcome>
  <primary_outcome>
    <measure>peripheral nervous system (non-volitional)</measure>
    <time_frame>1 day</time_frame>
    <description>electroneurography after posterior magnetic stimulation of the phrenic nerves</description>
  </primary_outcome>
  <primary_outcome>
    <measure>diaphragmal ultrasound - excursion (non-volitional)</measure>
    <time_frame>1 day</time_frame>
    <description>excursion of the diaphragm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>diaphragmal ultrasound - thickness (non-volitional)</measure>
    <time_frame>1 day</time_frame>
    <description>thickness of the diaphragm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>P0.1 (volitional)</measure>
    <time_frame>1 day</time_frame>
    <description>mouth occlusion pressure (kPa)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PImax (volitional)</measure>
    <time_frame>1 day</time_frame>
    <description>maximal inspiratory mouth pressure (kPa)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of PImax and transdiaphragmatic pressure</measure>
    <time_frame>1 day</time_frame>
    <description>Correlation between PImax and transdiaphragmatic pressure</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Obesity Hypoventilation Syndrome</condition>
  <arm_group>
    <arm_group_label>OHS or elevated OHS-risk (stages 0-IV)</arm_group_label>
    <description>stage 0: OHS-risk (OSA / no hypercapnia)
stage I: obesity associated hypoventilation (intermittent hypercapnia during sleep, arterial carbon dioxide partial pressure (PaCO2) or transcutaneous carbon dioxide partial pressure (PtcCO2) morning ~ evening), bicarbonate &lt; 27 mmol/L awake)
stage II: obesity associated hypoventilation (intermittent hypercapnia during sleep, PaCO2 or PtcCO2 morning &gt; evening, bicarbonate â‰¥ 27 mmol/L awake)
stage III: OHS (hypercapnia, carbon dioxide partial pressure (PCO2) &gt; 45 mmHg awake)
stage IV: OHS with end organ damage (hypercapnia , PCO2 &gt; 45 mmHg awake, cardiometabolic comorbidities)
diagnostic tests: magnetic phrenic nerve stimulation, diaphragmatic ultrasound</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>magnetic phrenic nerve stimulation</intervention_name>
    <description>cervical and cortical stimulation of N. Vagus</description>
    <arm_group_label>OHS or elevated OHS-risk (stages 0-IV)</arm_group_label>
    <other_name>diaphragmatic ultrasound</other_name>
    <other_name>spirometry</other_name>
    <other_name>Sleep-studies</other_name>
    <other_name>capnography</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with OHS or OHS-risk
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with BMI &gt; 30 and obesity-associated hypoventilation stages I - IV

          -  patients with BMI &gt; 30 and elevated OHS-risk (= obstructive sleep apnea without
             hypercapnia)

          -  age:18-80 years

          -  capacity to consent

        Exclusion Criteria:

          -  any other disease, that causes ventilatory insufficiency

          -  pacemaker, defibrillators or device for deep brain or vagus nerve stimulation

          -  esophagitis, Barrett-esophagus, esophageal cancer

          -  acute gastritis and ulcera ventriculi

          -  epilepsy

          -  any medical, psychological or other condition impairing the patient's ability to
             provide informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Winfried J Randerath, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wissenschaftliches Institut Bethanien e.V</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anja Pietzke-Calcagnile, Dr.</last_name>
    <phone>+49212636663</phone>
    <email>anja.pietzke-calcagnile@klinik-bethanien.de</email>
  </overall_contact>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>February 20, 2019</study_first_submitted>
  <study_first_submitted_qc>February 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2019</study_first_posted>
  <last_update_submitted>March 15, 2019</last_update_submitted>
  <last_update_submitted_qc>March 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypoventilation</mesh_term>
    <mesh_term>Obesity Hypoventilation Syndrome</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

